HCPCS code J2779 — Inj, susvimo 0.1 mg. Status: Active. Effective Jul 1, 2022. Source: CMS HCPCS Level II.

J2779

Active

Inj, susvimo 0.1 mg

Injection, ranibizumab, via intravitreal implant (susvimo), 0.1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jul 1, 2022
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9439

MUE — Medically Unlikely Edits

Maximum units of J2779 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 200
Practitioner Services 200

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
50242-0078-12 Susvimo
50242-0078-55 Susvimo

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2022-Q3
    Inj, susvimo 0.1 mg